M, A., G, E., H, H., C, S., & A, L. (2006). Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14). Medical oncology (Northwood, London, England), 23(2), 283. https://doi.org/10.1385/MO:23:2:283
Chicago Style (17th ed.) CitationM, Adde, Enblad G, Hagberg H, Sundström C, and Laurell A. "Outcome for Young High-risk Aggressive B-cell Lymphoma Patients Treated with CHOEP-14 and Rituximab (R-CHOEP-14)." Medical Oncology (Northwood, London, England) 23, no. 2 (2006): 283. https://doi.org/10.1385/MO:23:2:283.
MLA (9th ed.) CitationM, Adde, et al. "Outcome for Young High-risk Aggressive B-cell Lymphoma Patients Treated with CHOEP-14 and Rituximab (R-CHOEP-14)." Medical Oncology (Northwood, London, England), vol. 23, no. 2, 2006, p. 283, https://doi.org/10.1385/MO:23:2:283.